- Home
- SER vs BRAG Comparison
SER vs BRAG Comparison
Compare SER & BRAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SER | BRAG |
|---|---|---|
| Founded | 2017 | 2018 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Office Equipment/Supplies/Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.4M | 46.9M |
| IPO Year | 2024 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SER | BRAG |
|---|---|---|
| Price | $2.11 | $1.36 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 2 |
| Target Price | ★ $15.00 | $6.00 |
| AVG Volume (30 Days) | ★ 53.1K | 24.4K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $130,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.67 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 132.14 | N/A |
| 52 Week Low | $1.22 | $1.25 |
| 52 Week High | $5.83 | $3.20 |
Technical Indicators
Market Signals| Indicator | SER | BRAG |
|---|---|---|
| Relative Strength Index (RSI) | 38.92 | 40.05 |
| Support Level | $1.69 | $1.25 |
| Resistance Level | $2.29 | $1.82 |
| Average True Range (ATR) | 0.23 | 0.09 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 11.54 | 30.77 |
Price Performance
Historical ComparisonAbout SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The company has one reportable segment relating to the research and development of its POZ platform. The segment derives its revenues from Grant revenue. Its main product candidate, SER-252 for advanced Parkinson's disease, is anticipated to enter clinical trials.
About BRAG Bragg Gaming Group Inc.
Bragg Gaming Group Inc is predominantly a B2B online gaming technology platform and casino content aggregator. The company's proprietary studios offer high-performing, data-driven casino gaming titles from in-house brands Wild Streak, Spin, Atomic Slot Lab, Indigo Magic, and Oryx Gaming. It offers a full range of games including slot games, table games, card games, video bingo, scratch card games, virtual sports, and live dealer games which are featured on the company's PAM platform and also available for use on other gaming platforms offered by third parties. Geographically, the company generates a majority of its revenue from Malta, and the rest from Netherlands, Curacao, the United States, Croatia, Marshall Islands, Brazil, Isle of Man, Belgium, Czech Republic, and other regions.